MedTrace Logo

INSPIRE Pipeline™ Shield Post Approval Study

NCT05071963 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 246

Last updated 2026-02-27

No results posted yet for this study

Summary

The purpose of the Pipeline™ Flex Embolization Device with Shield Technology™ Post Approval Study (PAS) ("Pipeline™ Shield PAS") is to collect on-label use data in patients undergoing treatment for intracranial aneurysms (IA) using the Pipeline™ Flex Embolization Device with Shield Technology™ ("Pipeline™ Shield Device") in a real-world post approval setting within the United States.

Conditions

  • Intracranial Aneurysm

Interventions

DEVICE

Treatment of Intracranial Aneurysms

Embolization of aneurysms using the Pipeline™ Flex Embolization Device with Shield Technology™

Sponsors & Collaborators

  • Medtronic Neurovascular Clinical Affairs

    lead INDUSTRY

Principal Investigators

  • Harsh Sancheti · Medtronic

Eligibility

Min Age
22 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-12-20
Primary Completion
2026-07-31
Completion
2028-04-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05071963 on ClinicalTrials.gov